BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15078212)

  • 1. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.
    Jacobson KA; Costanzi S; Ohno M; Joshi BV; Besada P; Xu B; Tchilibon S
    Curr Top Med Chem; 2004; 4(8):805-19. PubMed ID: 15078212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2-pyrimidinergic receptors and their ligands.
    Müller CE
    Curr Pharm Des; 2002; 8(26):2353-69. PubMed ID: 12369950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists and antagonists for P2 receptors.
    Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
    Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors.
    Fumagalli M; Brambilla R; D'Ambrosi N; Volonté C; Matteoli M; Verderio C; Abbracchio MP
    Glia; 2003 Sep; 43(3):218-03. PubMed ID: 12898701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.
    Costanzi S; Mamedova L; Gao ZG; Jacobson KA
    J Med Chem; 2004 Oct; 47(22):5393-404. PubMed ID: 15481977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and characterization of purinergic contractions and relaxations in the rat urinary bladder.
    Aronsson P; Andersson M; Ericsson T; Giglio D
    Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):603-13. PubMed ID: 20406212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2 receptors activated by uracil nucleotides--an update.
    Brunschweiger A; Müller CE
    Curr Med Chem; 2006; 13(3):289-312. PubMed ID: 16475938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple P2Y receptors mediate contraction in guinea pig mesenteric vein.
    Mutafova-Yambolieva VN; Carolan BM; Harden TK; Keef KD
    Gen Pharmacol; 2000 Feb; 34(2):127-36. PubMed ID: 10974420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition at adenine nucleotide (P2) receptors in platelets.
    Jacobson KA; Mamedova L; Joshi BV; Besada P; Costanzi S
    Semin Thromb Hemost; 2005 Apr; 31(2):205-16. PubMed ID: 15852224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress.
    Yitzhaki S; Shneyvays V; Jacobson KA; Shainberg A
    Biochem Pharmacol; 2005 Apr; 69(8):1215-23. PubMed ID: 15794942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.
    Maruoka H; Jayasekara MP; Barrett MO; Franklin DA; de Castro S; Kim N; Costanzi S; Harden TK; Jacobson KA
    J Med Chem; 2011 Jun; 54(12):4018-33. PubMed ID: 21528910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
    Ko H; Carter RL; Cosyn L; Petrelli R; de Castro S; Besada P; Zhou Y; Cappellacci L; Franchetti P; Grifantini M; Van Calenbergh S; Harden TK; Jacobson KA
    Bioorg Med Chem; 2008 Jun; 16(12):6319-32. PubMed ID: 18514530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y receptor-mediated inhibition of voltage-activated Ca(2+) currents in PC12 cells.
    Vartian N; Boehm S
    Eur J Neurosci; 2001 Mar; 13(5):899-908. PubMed ID: 11264662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
    Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
    Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pharmacology of P2Y-receptors.
    von Kügelgen I; Wetter A
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tools and drugs for uracil nucleotide-activated P2Y receptors.
    Rafehi M; Müller CE
    Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
    Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
    J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.